A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study. (2022)
Attributed to:
The Oxford Single Cell Biology Consortium
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/20406207221084487
PubMed Identifier: 35371428
Publication URI: http://europepmc.org/abstract/MED/35371428
Type: Journal Article/Review
Volume: 13
Parent Publication: Therapeutic advances in hematology
ISSN: 2040-6207